In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug

Title
In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug
Authors
Keywords
Cancer treatment, Hepatocellular carcinoma, Crystal structure, Cell cycle and cell division, Cyclins, Drug discovery, Apoptosis, G1 phase
Journal
PLoS One
Volume 10, Issue 7, Pages e0132072
Publisher
Public Library of Science (PLoS)
Online
2015-07-07
DOI
10.1371/journal.pone.0132072

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started